GHK Basic (Tripeptide-1) (200mg)
GHK Basic (Tripeptide-1) (200mg) is a synthetic peptide research material intended for qualified laboratory, analytical, cosmetic-science, and formulation research. Also identified as Tripeptide-1 or GHK, this three-amino-acid peptide is used in scientific investigations involving peptide characterization, molecular interactions, stability, formulation compatibility, and skin-science-related research.
For laboratories and qualified buyers searching for GHK Basic (Tripeptide-1) (200mg), key purchasing considerations include verified ingredient identity, accurate quantity information, lot traceability, purity data, appropriate storage guidance, and available analytical documentation such as a Certificate of Analysis (COA).
For research use only. Not for human consumption.
What Is GHK Basic (Tripeptide-1)?
GHK, also known as Tripeptide-1, is a naturally occurring peptide sequence consisting of three amino acids: glycine, histidine, and lysine. In research, GHK may be studied in its basic or non-copper-bound form, allowing investigators to examine the characteristics of the peptide independently of copper complexation.
The term GHK Basic is used here to distinguish the material from copper-bound forms such as GHK-Cu. Researchers may investigate GHK Basic for peptide stability, molecular interactions, formulation characteristics, and behavior in controlled experimental systems.
The 200mg designation refers to the labeled quantity of GHK Basic (Tripeptide-1) supplied. Researchers should verify the exact molecular identity, sequence, purity, formulation, and analytical specifications through the manufacturer’s current documentation and lot-specific Certificate of Analysis where available.
Ingredients
GHK Basic / Tripeptide-1 — 200mg
Primary ingredient: GHK Basic, also known as Tripeptide-1.
The GHK peptide sequence consists of:
- Glycine
- Histidine
- Lysine
Together, these amino acids form the tripeptide commonly abbreviated as GHK.
Depending on the supplier’s formulation, additional carrier materials or excipients may be present. Buyers should review the current product label and lot-specific documentation for complete composition details.
GHK Basic (Tripeptide-1) Research Applications
Qualified researchers may investigate GHK Basic (Tripeptide-1) in areas such as:
- Synthetic peptide characterization,
- Tripeptide research,
- Molecular interaction studies,
- Peptide stability analysis,
- Cosmetic-science research,
- Formulation development,
- Structure-function investigations,
- Comparative peptide research,
- Analytical peptide testing,
- Controlled laboratory models.
These represent potential areas of scientific investigation and should not be interpreted as established medical, therapeutic, or cosmetic outcomes.
Why Choose GHK Basic (Tripeptide-1) (200mg)?
When sourcing GHK Basic (Tripeptide-1) (200mg) for qualified research, laboratories may prioritize product identity, documentation, and traceability.
Clearly Identified Tripeptide
The product identifies GHK Basic / Tripeptide-1 as its primary peptide ingredient, supporting accurate research documentation and inventory management.
200mg Labeled Quantity
The 200mg format provides a defined quantity of peptide material for laboratory and analytical applications. Whether this quantity is suitable depends on the requirements of the specific research protocol.
Quality Documentation
A lot-specific Certificate of Analysis (COA), where available, may provide information regarding product identity, purity, and analytical testing.
Lot Traceability
Lot and batch information can support laboratory recordkeeping and help researchers maintain organized documentation across experiments.
Suitable for Controlled Research
The product may be evaluated by qualified researchers according to established laboratory methods involving peptide characterization, stability, and formulation behavior.
Product Specifications
Product Name: GHK Basic (Tripeptide-1)
Labeled Quantity: 200mg
Primary Ingredient: GHK / Tripeptide-1
Peptide Components: Glycine, Histidine, Lysine
Product Category: Synthetic peptide research material
Intended Application: Qualified laboratory, analytical, and formulation research
Documentation: Manufacturer specifications and Certificate of Analysis where available
Human Consumption: Not intended for human consumption
Researchers should verify the current specifications and documentation associated with the exact product lot before purchase or laboratory use.
Dosage and Research Handling Guide
There is no established FDA-approved human dosage regimen for GHK Basic (Tripeptide-1) (200mg) as a concentrated research material. Therefore, this product should not be accompanied by a human dosing, injection, or self-administration schedule.
For legitimate laboratory research, experimental concentrations and preparation procedures should be established by appropriately qualified personnel according to the objectives and methodology of the research protocol.
Research parameters may depend on:
- Experimental objectives,
- Research model,
- Verified peptide identity,
- Product purity,
- Experimental concentration,
- Solubility,
- Formulation requirements,
- Stability characteristics,
- Analytical methodology,
- Institutional laboratory procedures.
Information concerning other forms of GHK, including copper-bound peptides or finished cosmetic formulations, should not automatically be applied to GHK Basic (Tripeptide-1) (200mg).
Storage and Handling
Store GHK Basic (Tripeptide-1) (200mg) according to the manufacturer’s current storage recommendations.
Before laboratory use, verify:
- Product identity,
- Labeled quantity,
- Lot or batch number,
- Packaging integrity,
- Storage requirements,
- Retest or expiration information where provided,
- Certificate of Analysis,
- Manufacturer specifications.
Do not use research material if packaging is compromised or if its identity and quality specifications cannot be adequately confirmed.
Frequently Asked Questions
What is GHK Basic (Tripeptide-1) (200mg)?
GHK Basic (Tripeptide-1) (200mg) is a synthetic tripeptide research material containing a labeled quantity of 200mg of GHK, also known as Tripeptide-1.
What are the ingredients in GHK?
The GHK sequence consists of three amino acids: glycine, histidine, and lysine.
What is the difference between GHK Basic and GHK-Cu?
GHK Basic refers to the peptide itself, while GHK-Cu refers to a copper-complexed form. Researchers should treat these as distinct materials and verify product specifications before comparison or experimentation.
Is GHK Basic an FDA-approved medication?
This research material should not be represented as an FDA-approved medication or as an approved treatment for skin conditions, hair loss, aging, wounds, or any other medical condition.
What is the recommended dosage?
There is no established FDA-approved human dosage for this concentrated research material. Qualified researchers should determine experimental concentrations according to an appropriate laboratory protocol.
Does 200mg indicate purity?
No. 200mg refers to the labeled quantity of material. Purity should be verified independently through the manufacturer’s specifications and available Certificate of Analysis.
What should buyers consider before purchasing?
Look for verified ingredient identity, clear quantity information, lot traceability, appropriate storage requirements, transparent specifications, and available quality documentation.
Final Conclusion
GHK Basic (Tripeptide-1) (200mg) is a specialized synthetic tripeptide research material intended for qualified laboratory, analytical, cosmetic-science, and formulation research. Its GHK sequence—glycine, histidine, and lysine—makes it relevant to controlled studies involving peptide characterization, molecular interactions, stability, and formulation development.
For buyers searching specifically for GHK Basic (Tripeptide-1) (200mg), prioritize verified product identity, transparent specifications, accurate ingredient information, lot traceability, appropriate storage guidance, and available Certificate of Analysis documentation.





Reviews
There are no reviews yet.